GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (NYSE:CRL) » Definitions » Cyclically Adjusted PS Ratio

Charles River Laboratories International (Charles River Laboratories International) Cyclically Adjusted PS Ratio : 3.87 (As of Apr. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Charles River Laboratories International Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Charles River Laboratories International's current share price is $229.03. Charles River Laboratories International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $59.18. Charles River Laboratories International's Cyclically Adjusted PS Ratio for today is 3.87.

The historical rank and industry rank for Charles River Laboratories International's Cyclically Adjusted PS Ratio or its related term are showing as below:

CRL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.13   Med: 3.86   Max: 11.01
Current: 3.87

During the past years, Charles River Laboratories International's highest Cyclically Adjusted PS Ratio was 11.01. The lowest was 2.13. And the median was 3.86.

CRL's Cyclically Adjusted PS Ratio is ranked worse than
68.15% of 135 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.21 vs CRL: 3.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Charles River Laboratories International's adjusted revenue per share data for the three months ended in Dec. 2023 was $19.746. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $59.18 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charles River Laboratories International Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Charles River Laboratories International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Cyclically Adjusted PS Ratio Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.53 6.60 8.40 4.15 3.99

Charles River Laboratories International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 3.69 3.72 3.37 3.99

Competitive Comparison of Charles River Laboratories International's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted PS Ratio falls into.



Charles River Laboratories International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Charles River Laboratories International's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=229.03/59.18
=3.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Charles River Laboratories International's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=19.746/129.4194*129.4194
=19.746

Current CPI (Dec. 2023) = 129.4194.

Charles River Laboratories International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 6.217 99.695 8.071
201406 7.155 100.560 9.208
201409 6.988 100.428 9.005
201412 6.933 99.070 9.057
201503 6.694 99.621 8.696
201506 7.141 100.684 9.179
201509 7.397 100.392 9.536
201512 7.405 99.792 9.603
201603 7.453 100.470 9.600
201606 9.058 101.688 11.528
201609 8.863 101.861 11.261
201612 9.661 101.863 12.275
201703 9.206 102.862 11.583
201706 9.704 103.349 12.152
201709 9.594 104.136 11.923
201712 9.778 104.011 12.167
201803 10.117 105.290 12.436
201806 11.934 106.317 14.527
201809 11.866 106.507 14.419
201812 12.347 105.998 15.075
201903 12.223 107.251 14.750
201906 13.241 108.070 15.857
201909 13.436 108.329 16.052
201912 13.853 108.420 16.536
202003 14.151 108.902 16.817
202006 13.585 108.767 16.164
202009 14.660 109.815 17.277
202012 15.410 109.897 18.148
202103 16.144 111.754 18.696
202106 17.817 114.631 20.115
202109 17.377 115.734 19.432
202112 17.533 117.630 19.290
202203 17.807 121.301 18.999
202206 18.976 125.017 19.644
202209 19.288 125.227 19.934
202212 21.419 125.222 22.137
202303 20.016 127.348 20.342
202306 20.594 128.729 20.704
202309 19.893 129.860 19.826
202312 19.746 129.419 19.746

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Charles River Laboratories International  (NYSE:CRL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Charles River Laboratories International Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (Charles River Laboratories International) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Executives
Victoria L Creamer officer: EVP & Chief People Officer 164 PINE HILL ROAD, NEW FAIRFIELD CT 06812
Joseph W Laplume officer: EVP, Corp Strategy & Develop 251 BALLARDVALE STREET, WILMINGTON MA 01887
Birgit Girshick officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
James C Foster director, officer: President and CEO 251 BALLARDVALE ST, WILMINGTON MA 01887
Richard F Wallman director HONEYWELL, 101 COLUMBIA ROAD, MORRISTOWN NJ 07962
William D Barbo officer: Corporate Executive VP & CCO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Michael Gunnar Knell officer: CSVP&Chief Accounting Officer BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
George Massaro director
Shannon M Parisotto officer: CEVP, Disc & Safety Assessment 251 BALLARDVALE ST, WILMINGTON MA 01887
Flavia Pease officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
David Ross Smith officer: Corporate Executive VP & CFO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Deborah Turner Kochevar director 251 BALLARDVALE STREET, WILMINGTON MA 01887
Milne George M Jr director
Stephen D Chubb director C/O MATRITECH INC, 330 NEVADA STREET, NEWTON MA 02460
George Llado director 251 BALLARDVALE STREET, WILMINGTON MA 01887